NASDAQ Extends Temporary Suspension of Bid Price and Market Value of Publicly Held Shares Requirements; Oscient Pharmaceuticals Corporation Compliance Period Extended to October 6, 2009

Published: Mar 24, 2009

WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) has received notification from NASDAQ OMX (“NASDAQ”) that, given the current extraordinary market conditions, NASDAQ has further extended the temporary suspension of the rules requiring a minimum market value of publicly held shares (“MVPHS”) and a minimum $1 closing bid price by 90 days.

Back to news